

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 5.02273907 |
| 2 | sodium ion export (GO:0071436) | 4.95682183 |
| 3 | gamma-aminobutyric acid transport (GO:0015812) | 4.77669675 |
| 4 | alanine transport (GO:0032328) | 4.20129041 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.09786904 |
| 6 | cellular sodium ion homeostasis (GO:0006883) | 4.09718761 |
| 7 | C4-dicarboxylate transport (GO:0015740) | 4.09656138 |
| 8 | L-amino acid import (GO:0043092) | 4.05367985 |
| 9 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.82625671 |
| 10 | potassium ion import (GO:0010107) | 3.78721110 |
| 11 | cell communication by electrical coupling (GO:0010644) | 3.76043589 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.71477465 |
| 13 | lysine catabolic process (GO:0006554) | 3.66583520 |
| 14 | lysine metabolic process (GO:0006553) | 3.66583520 |
| 15 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.63938900 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.55435884 |
| 17 | amino acid import (GO:0043090) | 3.53325137 |
| 18 | glutamate metabolic process (GO:0006536) | 3.42187418 |
| 19 | postsynaptic membrane organization (GO:0001941) | 3.38160921 |
| 20 | negative regulation of sodium ion transport (GO:0010766) | 3.28479056 |
| 21 | potassium ion homeostasis (GO:0055075) | 3.28384722 |
| 22 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.27144115 |
| 23 | low-density lipoprotein particle remodeling (GO:0034374) | 3.25531122 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.23027831 |
| 25 | neurotransmitter secretion (GO:0007269) | 3.22210767 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.22103515 |
| 27 | cerebellar granule cell differentiation (GO:0021707) | 3.20163117 |
| 28 | proline transport (GO:0015824) | 3.18785013 |
| 29 | phosphate ion transport (GO:0006817) | 3.17818409 |
| 30 | vocalization behavior (GO:0071625) | 3.16207146 |
| 31 | drug transmembrane transport (GO:0006855) | 3.11793606 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.11397220 |
| 33 | drug catabolic process (GO:0042737) | 3.11292032 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 3.10719488 |
| 35 | urate metabolic process (GO:0046415) | 3.09072972 |
| 36 | axon ensheathment in central nervous system (GO:0032291) | 3.05851685 |
| 37 | central nervous system myelination (GO:0022010) | 3.05851685 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 3.03312774 |
| 39 | phosphate ion transmembrane transport (GO:0035435) | 3.02943224 |
| 40 | synaptic vesicle maturation (GO:0016188) | 3.02243247 |
| 41 | glutamate secretion (GO:0014047) | 3.01576943 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.00722896 |
| 43 | cysteine metabolic process (GO:0006534) | 3.00275598 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 2.98930769 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97820626 |
| 46 | L-phenylalanine catabolic process (GO:0006559) | 2.97820626 |
| 47 | glycine transport (GO:0015816) | 2.97726918 |
| 48 | exogenous drug catabolic process (GO:0042738) | 2.97242338 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.95934554 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91574936 |
| 51 | astrocyte differentiation (GO:0048708) | 2.90433932 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 2.90244337 |
| 53 | neuronal action potential propagation (GO:0019227) | 2.88309294 |
| 54 | glyoxylate metabolic process (GO:0046487) | 2.87795331 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85905966 |
| 56 | neuronal ion channel clustering (GO:0045161) | 2.84949837 |
| 57 | neurotransmitter transport (GO:0006836) | 2.83218913 |
| 58 | dicarboxylic acid catabolic process (GO:0043649) | 2.81564235 |
| 59 | transepithelial transport (GO:0070633) | 2.80481747 |
| 60 | presynaptic membrane assembly (GO:0097105) | 2.80009822 |
| 61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.79753994 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 2.77765070 |
| 63 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.77496182 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77086387 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 2.77086387 |
| 66 | acidic amino acid transport (GO:0015800) | 2.75185843 |
| 67 | one-carbon compound transport (GO:0019755) | 2.74425605 |
| 68 | peripheral nervous system axon ensheathment (GO:0032292) | 2.73520133 |
| 69 | myelination in peripheral nervous system (GO:0022011) | 2.73520133 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.72336569 |
| 71 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.71947730 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 2.71031415 |
| 73 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68753285 |
| 74 | homocysteine metabolic process (GO:0050667) | 2.68678915 |
| 75 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.67226158 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 2.66245167 |
| 77 | drug transport (GO:0015893) | 2.65228412 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 2.65088646 |
| 79 | prepulse inhibition (GO:0060134) | 2.64556400 |
| 80 | import into cell (GO:0098657) | 2.63899572 |
| 81 | aromatic amino acid family catabolic process (GO:0009074) | 2.63633577 |
| 82 | response to auditory stimulus (GO:0010996) | 2.63541070 |
| 83 | neurotransmitter uptake (GO:0001504) | 2.62731621 |
| 84 | exploration behavior (GO:0035640) | 2.62686454 |
| 85 | membrane hyperpolarization (GO:0060081) | 2.62354659 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 2.60985081 |
| 87 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.60845699 |
| 88 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.60618977 |
| 89 | metanephric nephron tubule development (GO:0072234) | 2.59265340 |
| 90 | metanephric tubule development (GO:0072170) | 2.59265340 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59250548 |
| 92 | negative regulation of protein localization to cell surface (GO:2000009) | 2.58967411 |
| 93 | relaxation of cardiac muscle (GO:0055119) | 2.58965348 |
| 94 | sperm capacitation (GO:0048240) | 2.58699368 |
| 95 | auditory behavior (GO:0031223) | 2.58153942 |
| 96 | synaptic vesicle exocytosis (GO:0016079) | 2.57775249 |
| 97 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.56384374 |
| 98 | long-term memory (GO:0007616) | 2.56277873 |
| 99 | cell communication involved in cardiac conduction (GO:0086065) | 2.55917889 |
| 100 | cGMP-mediated signaling (GO:0019934) | 2.55259873 |
| 101 | L-glutamate transport (GO:0015813) | 2.55105866 |
| 102 | glutamine family amino acid catabolic process (GO:0009065) | 2.54055088 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.53829535 |
| 104 | regulation of synapse structural plasticity (GO:0051823) | 2.52938305 |
| 105 | sodium ion homeostasis (GO:0055078) | 2.52316217 |
| 106 | neuron cell-cell adhesion (GO:0007158) | 2.52110713 |
| 107 | presynaptic membrane organization (GO:0097090) | 2.51789050 |
| 108 | nephron tubule formation (GO:0072079) | 2.50170621 |
| 109 | dicarboxylic acid transport (GO:0006835) | 2.50056789 |
| 110 | neuron-neuron synaptic transmission (GO:0007270) | 2.47635968 |
| 111 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.47337912 |
| 112 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.44684669 |
| 113 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.43055820 |
| 114 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.41887308 |
| 115 | quaternary ammonium group transport (GO:0015697) | 2.40719308 |
| 116 | layer formation in cerebral cortex (GO:0021819) | 2.39641575 |
| 117 | protein-lipid complex remodeling (GO:0034368) | 2.39006928 |
| 118 | macromolecular complex remodeling (GO:0034367) | 2.39006928 |
| 119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.39006928 |
| 120 | membrane repolarization (GO:0086009) | 2.38937065 |
| 121 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.38465298 |
| 122 | cellular amino acid catabolic process (GO:0009063) | 2.37386681 |
| 123 | alpha-amino acid catabolic process (GO:1901606) | 2.36643400 |
| 124 | serine family amino acid catabolic process (GO:0009071) | 2.36535628 |
| 125 | fluid transport (GO:0042044) | 2.35507930 |
| 126 | * bicarbonate transport (GO:0015701) | 2.33656855 |
| 127 | metanephric nephron epithelium development (GO:0072243) | 2.33449393 |
| 128 | otic vesicle formation (GO:0030916) | 2.30850679 |
| 129 | relaxation of muscle (GO:0090075) | 2.28885300 |
| 130 | regulation of synaptic vesicle transport (GO:1902803) | 2.27780129 |
| 131 | negative regulation of hormone metabolic process (GO:0032351) | 2.26914828 |
| 132 | photoreceptor cell differentiation (GO:0046530) | 2.26676739 |
| 133 | eye photoreceptor cell differentiation (GO:0001754) | 2.26676739 |
| 134 | water transport (GO:0006833) | 2.26188150 |
| 135 | glomerular basement membrane development (GO:0032836) | 2.26117980 |
| 136 | macroautophagy (GO:0016236) | 2.24433881 |
| 137 | righting reflex (GO:0060013) | 2.23902621 |
| 138 | astrocyte development (GO:0014002) | 2.22591592 |
| 139 | response to mercury ion (GO:0046689) | 2.22134391 |
| 140 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.21988093 |
| 141 | response to lead ion (GO:0010288) | 2.21774280 |
| 142 | regulation of protein glycosylation (GO:0060049) | 2.19739667 |
| 143 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17681724 |
| 144 | nephron tubule development (GO:0072080) | 2.17220563 |
| 145 | camera-type eye morphogenesis (GO:0048593) | 2.16377373 |
| 146 | ethanol oxidation (GO:0006069) | 2.16057375 |
| 147 | positive regulation of potassium ion transport (GO:0043268) | 2.15303659 |
| 148 | regulation of ARF protein signal transduction (GO:0032012) | 2.15238573 |
| 149 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.14673442 |
| 150 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.14116364 |
| 151 | renal absorption (GO:0070293) | 2.12946297 |
| 152 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.12713016 |
| 153 | regulation of actin filament-based movement (GO:1903115) | 2.11649235 |
| 154 | cyclic-nucleotide-mediated signaling (GO:0019935) | 2.11521084 |
| 155 | transcytosis (GO:0045056) | 2.10652825 |
| 156 | membrane assembly (GO:0071709) | 2.09882024 |
| 157 | metanephric epithelium development (GO:0072207) | 2.09193034 |
| 158 | cell volume homeostasis (GO:0006884) | 2.05426995 |
| 159 | positive regulation of sodium ion transport (GO:0010765) | 2.03683798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.62277409 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.92660656 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73945107 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64046783 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46071344 |
| 6 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21121906 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21121906 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19908000 |
| 9 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19109502 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18470220 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16154857 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.15392290 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12319110 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11456244 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07534234 |
| 16 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04912553 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04303756 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99725790 |
| 19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85373614 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84447808 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82150155 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80287194 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77790477 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74956083 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72450832 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72285324 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67925671 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.65264001 |
| 29 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.63719413 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62432606 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62027694 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56352454 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52412479 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51798755 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49950288 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48447666 |
| 37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.44670601 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44405133 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41524901 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40986763 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.40103893 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38949344 |
| 43 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37943211 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36744860 |
| 45 | RXR_22108803_ChIP-Seq_LS180_Human | 1.34332529 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33878332 |
| 47 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33743238 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31088704 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30412757 |
| 50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26871746 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26574111 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24872464 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24014974 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19387554 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19138990 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16645004 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16525128 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16356869 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15024296 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14901867 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13900917 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13799965 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13545962 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12813617 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.12677407 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12463495 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11841002 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11500483 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10994974 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10643310 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10629465 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10473785 |
| 73 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10208160 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09860350 |
| 75 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09433076 |
| 76 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08723381 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08645263 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07192520 |
| 79 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06805643 |
| 80 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05748938 |
| 81 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05665277 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05146420 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05013863 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04729321 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04429883 |
| 86 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03904523 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03590931 |
| 88 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03256662 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03013044 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01849769 |
| 91 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.01782428 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01691475 |
| 93 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00402691 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99721931 |
| 95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99619011 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99546490 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98070556 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97481438 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97345617 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96687493 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96374643 |
| 102 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.94793589 |
| 103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94622650 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93672783 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92569817 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92515506 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92021704 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91784774 |
| 109 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91511425 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91288685 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90960756 |
| 112 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90491011 |
| 113 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90135689 |
| 114 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90135689 |
| 115 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87820757 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87034925 |
| 117 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85554595 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84747334 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84652838 |
| 120 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84300747 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84256711 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83662258 |
| 123 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83545337 |
| 124 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83436717 |
| 125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83281456 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82715720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.32243200 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.05929195 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.38074411 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.91153250 |
| 5 | MP0009046_muscle_twitch | 2.83892793 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.80922603 |
| 7 | MP0004885_abnormal_endolymph | 2.79431610 |
| 8 | MP0004270_analgesia | 2.71869714 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.63531393 |
| 10 | MP0005332_abnormal_amino_acid | 2.63257131 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.54259936 |
| 12 | MP0003690_abnormal_glial_cell | 2.48471243 |
| 13 | MP0009745_abnormal_behavioral_response | 2.47741501 |
| 14 | MP0002064_seizures | 2.34765898 |
| 15 | MP0004858_abnormal_nervous_system | 2.23533410 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.22257609 |
| 17 | MP0003868_abnormal_feces_composition | 2.20401668 |
| 18 | MP0005365_abnormal_bile_salt | 2.19028494 |
| 19 | MP0001486_abnormal_startle_reflex | 2.13963102 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.13643018 |
| 21 | MP0002822_catalepsy | 2.13629878 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08878803 |
| 23 | MP0003329_amyloid_beta_deposits | 2.07798259 |
| 24 | MP0003880_abnormal_central_pattern | 2.03663102 |
| 25 | MP0000462_abnormal_digestive_system | 1.96770366 |
| 26 | * MP0004043_abnormal_pH_regulation | 1.89724395 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.89497005 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.89272110 |
| 29 | MP0002272_abnormal_nervous_system | 1.84966857 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.84847522 |
| 31 | MP0005248_abnormal_Harderian_gland | 1.84340033 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.78688631 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.78325919 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.73872004 |
| 35 | MP0003252_abnormal_bile_duct | 1.73161251 |
| 36 | MP0008569_lethality_at_weaning | 1.69924876 |
| 37 | MP0003633_abnormal_nervous_system | 1.66384230 |
| 38 | MP0002132_abnormal_respiratory_system | 1.65770981 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.63071966 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.62614911 |
| 41 | MP0003878_abnormal_ear_physiology | 1.62091557 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.62091557 |
| 43 | MP0003195_calcinosis | 1.59401065 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.58612207 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.58333133 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.57121655 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.55702207 |
| 48 | MP0000613_abnormal_salivary_gland | 1.54453605 |
| 49 | MP0002736_abnormal_nociception_after | 1.45460038 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.43767540 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 1.43724930 |
| 52 | MP0003045_fibrosis | 1.36453610 |
| 53 | * MP0001664_abnormal_digestion | 1.33465791 |
| 54 | MP0003075_altered_response_to | 1.31113684 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30297934 |
| 56 | MP0003631_nervous_system_phenotype | 1.29320551 |
| 57 | MP0000604_amyloidosis | 1.24350458 |
| 58 | MP0001984_abnormal_olfaction | 1.24066022 |
| 59 | MP0004142_abnormal_muscle_tone | 1.23655803 |
| 60 | MP0000566_synostosis | 1.23454593 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.21942286 |
| 62 | MP0002163_abnormal_gland_morphology | 1.21632162 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.20739595 |
| 64 | MP0002089_abnormal_postnatal_growth/wei | 1.20479024 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.20186986 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.19697438 |
| 67 | * MP0001765_abnormal_ion_homeostasis | 1.14794067 |
| 68 | MP0005535_abnormal_body_temperature | 1.11739606 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.11728048 |
| 70 | MP0004924_abnormal_behavior | 1.11728048 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.11117434 |
| 72 | MP0002928_abnormal_bile_duct | 1.11099035 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.11039455 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 1.10878020 |
| 75 | MP0001970_abnormal_pain_threshold | 1.10528769 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.10194807 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.08839023 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.08578176 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.07496527 |
| 80 | MP0002735_abnormal_chemical_nociception | 1.06965893 |
| 81 | MP0008872_abnormal_physiological_respon | 1.05169767 |
| 82 | MP0000920_abnormal_myelination | 1.04465476 |
| 83 | MP0003634_abnormal_glial_cell | 1.04035520 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.03519279 |
| 85 | MP0003646_muscle_fatigue | 1.01069531 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.98173049 |
| 87 | MP0001756_abnormal_urination | 0.98154084 |
| 88 | MP0000778_abnormal_nervous_system | 0.98125592 |
| 89 | MP0001177_atelectasis | 0.98006487 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.97940344 |
| 91 | MP0003632_abnormal_nervous_system | 0.96273010 |
| 92 | MP0000026_abnormal_inner_ear | 0.95482234 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.94215644 |
| 94 | MP0001666_abnormal_nutrient_absorption | 0.93895966 |
| 95 | MP0005409_darkened_coat_color | 0.92770609 |
| 96 | MP0009840_abnormal_foam_cell | 0.91380532 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.90559640 |
| 98 | MP0001958_emphysema | 0.90315305 |
| 99 | MP0002168_other_aberrant_phenotype | 0.89437861 |
| 100 | MP0004742_abnormal_vestibular_system | 0.88644021 |
| 101 | MP0001270_distended_abdomen | 0.88571462 |
| 102 | MP0005670_abnormal_white_adipose | 0.87738005 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.87334707 |
| 104 | MP0003091_abnormal_cell_migration | 0.86448308 |
| 105 | MP0003879_abnormal_hair_cell | 0.86301897 |
| 106 | MP0000534_abnormal_ureter_morphology | 0.85869357 |
| 107 | MP0000955_abnormal_spinal_cord | 0.85386364 |
| 108 | MP0002229_neurodegeneration | 0.85350203 |
| 109 | MP0004272_abnormal_basement_membrane | 0.84760659 |
| 110 | MP0004130_abnormal_muscle_cell | 0.81589674 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.81423263 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.81186485 |
| 113 | MP0008874_decreased_physiological_sensi | 0.81088213 |
| 114 | MP0002882_abnormal_neuron_morphology | 0.79926997 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.79847810 |
| 116 | MP0002254_reproductive_system_inflammat | 0.79838174 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.78619752 |
| 118 | MP0003283_abnormal_digestive_organ | 0.77417409 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.76222746 |
| 120 | MP0005083_abnormal_biliary_tract | 0.75539051 |
| 121 | MP0002184_abnormal_innervation | 0.74438855 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.74344677 |
| 123 | * MP0005636_abnormal_mineral_homeostasis | 0.74200774 |
| 124 | MP0003136_yellow_coat_color | 0.73391392 |
| 125 | MP0002102_abnormal_ear_morphology | 0.73246772 |
| 126 | MP0004085_abnormal_heartbeat | 0.72034161 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.70533875 |
| 128 | MP0004811_abnormal_neuron_physiology | 0.69258092 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.68742639 |
| 130 | MP0002152_abnormal_brain_morphology | 0.68329840 |
| 131 | MP0005166_decreased_susceptibility_to | 0.67762318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 5.21446673 |
| 2 | Metabolic alkalosis (HP:0200114) | 4.62150674 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 4.26004530 |
| 4 | Focal motor seizures (HP:0011153) | 4.22116252 |
| 5 | Abnormal urine output (HP:0012590) | 3.97271211 |
| 6 | Gout (HP:0001997) | 3.95022042 |
| 7 | Hyperglycinuria (HP:0003108) | 3.88477325 |
| 8 | Myokymia (HP:0002411) | 3.72517299 |
| 9 | Hemiplegia (HP:0002301) | 3.66590287 |
| 10 | Polyuria (HP:0000103) | 3.59694917 |
| 11 | Abnormality of renal excretion (HP:0011036) | 3.59195972 |
| 12 | Confusion (HP:0001289) | 3.52617799 |
| 13 | Hypomagnesemia (HP:0002917) | 3.50868322 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43579488 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 3.43579488 |
| 16 | Action tremor (HP:0002345) | 3.42378378 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.40080288 |
| 18 | Facial shape deformation (HP:0011334) | 3.29749849 |
| 19 | Potter facies (HP:0002009) | 3.29749849 |
| 20 | Polydipsia (HP:0001959) | 3.21217405 |
| 21 | Abnormal drinking behavior (HP:0030082) | 3.21217405 |
| 22 | Ketoacidosis (HP:0001993) | 3.18642695 |
| 23 | Status epilepticus (HP:0002133) | 3.16247281 |
| 24 | Focal seizures (HP:0007359) | 3.13275340 |
| 25 | Hemiparesis (HP:0001269) | 3.12138404 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.08605699 |
| 27 | Alkalosis (HP:0001948) | 3.03837999 |
| 28 | Abnormality of binocular vision (HP:0011514) | 3.03515488 |
| 29 | Diplopia (HP:0000651) | 3.03515488 |
| 30 | Dysdiadochokinesis (HP:0002075) | 2.96148671 |
| 31 | Ileus (HP:0002595) | 2.92856980 |
| 32 | Ketosis (HP:0001946) | 2.92659925 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.90160747 |
| 34 | Aplasia involving bones of the extremities (HP:0009825) | 2.88184938 |
| 35 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.88184938 |
| 36 | Aplasia of the phalanges of the hand (HP:0009802) | 2.88184938 |
| 37 | Obstructive sleep apnea (HP:0002870) | 2.87485003 |
| 38 | Progressive cerebellar ataxia (HP:0002073) | 2.84444465 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.83179062 |
| 40 | Hyperglycinemia (HP:0002154) | 2.82838859 |
| 41 | Neonatal short-limb short stature (HP:0008921) | 2.82024911 |
| 42 | Abnormality of magnesium homeostasis (HP:0004921) | 2.81178322 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 2.79857543 |
| 44 | Glomerulonephritis (HP:0000099) | 2.79620391 |
| 45 | Tetraplegia (HP:0002445) | 2.77579130 |
| 46 | Exocrine pancreatic insufficiency (HP:0001738) | 2.75128484 |
| 47 | Hyperammonemia (HP:0001987) | 2.73947281 |
| 48 | Xanthomatosis (HP:0000991) | 2.73330777 |
| 49 | Alacrima (HP:0000522) | 2.73293435 |
| 50 | Hyperaldosteronism (HP:0000859) | 2.72838177 |
| 51 | Generalized tonic-clonic seizures (HP:0002069) | 2.71901639 |
| 52 | Rectal prolapse (HP:0002035) | 2.71708490 |
| 53 | Partial duplication of thumb phalanx (HP:0009944) | 2.67733167 |
| 54 | Intention tremor (HP:0002080) | 2.62676281 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.62487465 |
| 56 | Increased purine levels (HP:0004368) | 2.61901236 |
| 57 | Hyperuricemia (HP:0002149) | 2.61901236 |
| 58 | Hyperventilation (HP:0002883) | 2.61129515 |
| 59 | Megalencephaly (HP:0001355) | 2.53842143 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.51736890 |
| 61 | Epileptic encephalopathy (HP:0200134) | 2.51518331 |
| 62 | Postural instability (HP:0002172) | 2.46732085 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.44578026 |
| 64 | Adrenal overactivity (HP:0002717) | 2.44516819 |
| 65 | Hyperlipoproteinemia (HP:0010980) | 2.43098527 |
| 66 | Abnormality of chloride homeostasis (HP:0011422) | 2.42604697 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.42518562 |
| 68 | Widely patent fontanelles and sutures (HP:0004492) | 2.40678266 |
| 69 | Bronchomalacia (HP:0002780) | 2.38669922 |
| 70 | Arterial tortuosity (HP:0005116) | 2.38592305 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.33880512 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.33880512 |
| 73 | Hyperkalemia (HP:0002153) | 2.33630096 |
| 74 | Visual hallucinations (HP:0002367) | 2.33495322 |
| 75 | Partial duplication of the phalanx of hand (HP:0009999) | 2.32918590 |
| 76 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32696524 |
| 77 | Male infertility (HP:0003251) | 2.32051744 |
| 78 | Intrahepatic cholestasis (HP:0001406) | 2.29984295 |
| 79 | Renal salt wasting (HP:0000127) | 2.29398089 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28822132 |
| 81 | Bundle branch block (HP:0011710) | 2.28386685 |
| 82 | Scanning speech (HP:0002168) | 2.27891528 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.23653244 |
| 84 | Hypoalphalipoproteinemia (HP:0003233) | 2.22121078 |
| 85 | Vascular tortuosity (HP:0004948) | 2.18592345 |
| 86 | Dysmetria (HP:0001310) | 2.15185661 |
| 87 | Abnormality of the right ventricle (HP:0001707) | 2.13233458 |
| 88 | Shallow orbits (HP:0000586) | 2.13133960 |
| 89 | Vascular calcification (HP:0004934) | 2.12679593 |
| 90 | Gaze-evoked nystagmus (HP:0000640) | 2.12678129 |
| 91 | Decreased lacrimation (HP:0000633) | 2.12552772 |
| 92 | Fat malabsorption (HP:0002630) | 2.10011749 |
| 93 | Deep venous thrombosis (HP:0002625) | 2.09988592 |
| 94 | Ankle clonus (HP:0011448) | 2.09952137 |
| 95 | Dysmetric saccades (HP:0000641) | 2.09945553 |
| 96 | Hypoglycemic coma (HP:0001325) | 2.09883097 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 2.07979377 |
| 98 | Absence seizures (HP:0002121) | 2.06941028 |
| 99 | Mitral stenosis (HP:0001718) | 2.04919876 |
| 100 | Abnormality of sodium homeostasis (HP:0010931) | 2.04170612 |
| 101 | Papilledema (HP:0001085) | 2.01006193 |
| 102 | Cerebral inclusion bodies (HP:0100314) | 1.99611633 |
| 103 | Nephritis (HP:0000123) | 1.98998146 |
| 104 | Anxiety (HP:0000739) | 1.98169852 |
| 105 | Hypercalciuria (HP:0002150) | 1.97978491 |
| 106 | Febrile seizures (HP:0002373) | 1.97323387 |
| 107 | Vertebral arch anomaly (HP:0008438) | 1.96588863 |
| 108 | Abnormal social behavior (HP:0012433) | 1.96013133 |
| 109 | Impaired social interactions (HP:0000735) | 1.96013133 |
| 110 | Neoplasm of the heart (HP:0100544) | 1.95948752 |
| 111 | Enlarged kidneys (HP:0000105) | 1.95538221 |
| 112 | Thickened helices (HP:0000391) | 1.94679011 |
| 113 | Polyphagia (HP:0002591) | 1.94241304 |
| 114 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94117687 |
| 115 | Dialeptic seizures (HP:0011146) | 1.91541666 |
| 116 | Hypokalemia (HP:0002900) | 1.90859038 |
| 117 | Sleep apnea (HP:0010535) | 1.89296790 |
| 118 | Depression (HP:0000716) | 1.87076107 |
| 119 | Cardiovascular calcification (HP:0011915) | 1.86805187 |
| 120 | Broad-based gait (HP:0002136) | 1.85239616 |
| 121 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.85127107 |
| 122 | Synostosis involving the elbow (HP:0003938) | 1.84910886 |
| 123 | Humeroradial synostosis (HP:0003041) | 1.84910886 |
| 124 | Atonic seizures (HP:0010819) | 1.84595020 |
| 125 | Broad metatarsal (HP:0001783) | 1.83609641 |
| 126 | Truncal ataxia (HP:0002078) | 1.81973040 |
| 127 | Mixed hearing impairment (HP:0000410) | 1.81428821 |
| 128 | Hyponatremia (HP:0002902) | 1.79837268 |
| 129 | Pheochromocytoma (HP:0002666) | 1.77794037 |
| 130 | Hypolipoproteinemia (HP:0010981) | 1.77726772 |
| 131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77645094 |
| 132 | Flat acetabular roof (HP:0003180) | 1.77598621 |
| 133 | Torticollis (HP:0000473) | 1.76079515 |
| 134 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.75280325 |
| 135 | Turricephaly (HP:0000262) | 1.74495897 |
| 136 | Abnormality of potassium homeostasis (HP:0011042) | 1.74346563 |
| 137 | Congenital sensorineural hearing impairment (HP:0008527) | 1.70264347 |
| 138 | Visceral angiomatosis (HP:0100761) | 1.68508940 |
| 139 | Aortic aneurysm (HP:0004942) | 1.67967100 |
| 140 | Cubitus valgus (HP:0002967) | 1.65191661 |
| 141 | Abnormal biliary tract morphology (HP:0012440) | 1.64285583 |
| 142 | Split foot (HP:0001839) | 1.63734826 |
| 143 | Abnormality of the dental root (HP:0006486) | 1.63562074 |
| 144 | Taurodontia (HP:0000679) | 1.63562074 |
| 145 | Abnormality of permanent molar morphology (HP:0011071) | 1.63562074 |
| 146 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.63135812 |
| 147 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.60614804 |
| 148 | Syncope (HP:0001279) | 1.60383988 |
| 149 | Abnormality of molar (HP:0011077) | 1.59418209 |
| 150 | Abnormality of molar morphology (HP:0011070) | 1.59418209 |
| 151 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.58567618 |
| 152 | Polar cataract (HP:0010696) | 1.57792788 |
| 153 | Overgrowth (HP:0001548) | 1.56567149 |
| 154 | Hyperextensible skin (HP:0000974) | 1.55544133 |
| 155 | Abnormal pancreas size (HP:0012094) | 1.53852798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.41353235 |
| 2 | NTRK3 | 3.23938520 |
| 3 | OXSR1 | 2.96942038 |
| 4 | AKT3 | 2.86552198 |
| 5 | WNK4 | 2.77935792 |
| 6 | NTRK2 | 2.66638434 |
| 7 | WNK3 | 2.63436016 |
| 8 | TNIK | 2.60730596 |
| 9 | MAP3K9 | 2.16820296 |
| 10 | PRKD3 | 2.14485129 |
| 11 | MAP3K4 | 2.11714164 |
| 12 | LMTK2 | 2.04236587 |
| 13 | SGK223 | 2.01524634 |
| 14 | SGK494 | 2.01524634 |
| 15 | SGK2 | 1.92304909 |
| 16 | STK38 | 1.90175400 |
| 17 | MINK1 | 1.85656136 |
| 18 | MAP2K4 | 1.78874470 |
| 19 | SGK3 | 1.77405795 |
| 20 | PHKG1 | 1.68878143 |
| 21 | PHKG2 | 1.68878143 |
| 22 | MARK1 | 1.68666191 |
| 23 | STK39 | 1.64264878 |
| 24 | DAPK2 | 1.63784009 |
| 25 | NTRK1 | 1.60033229 |
| 26 | MAP2K7 | 1.59763665 |
| 27 | STK38L | 1.59621932 |
| 28 | CAMKK1 | 1.59531819 |
| 29 | PIK3CA | 1.59527826 |
| 30 | PRKG2 | 1.57181013 |
| 31 | PAK6 | 1.54529743 |
| 32 | WNK1 | 1.51585462 |
| 33 | PINK1 | 1.49735255 |
| 34 | RIPK1 | 1.37931251 |
| 35 | SIK1 | 1.36349612 |
| 36 | EPHA3 | 1.26079184 |
| 37 | CAMKK2 | 1.23553943 |
| 38 | KSR2 | 1.21702685 |
| 39 | PRKCG | 1.19067394 |
| 40 | CASK | 1.14870194 |
| 41 | CDK5 | 1.10201609 |
| 42 | INSRR | 1.09976750 |
| 43 | BCKDK | 1.09027108 |
| 44 | CAMK1G | 1.04968135 |
| 45 | PRKCH | 1.04788731 |
| 46 | MYLK | 1.03396528 |
| 47 | DMPK | 1.01978025 |
| 48 | TRIB3 | 1.00006747 |
| 49 | UHMK1 | 0.95643776 |
| 50 | MAP3K13 | 0.95436924 |
| 51 | MAPK15 | 0.93536211 |
| 52 | TYRO3 | 0.93532045 |
| 53 | PAK3 | 0.93460976 |
| 54 | SGK1 | 0.91413529 |
| 55 | MAP3K7 | 0.90908373 |
| 56 | RIPK4 | 0.89273035 |
| 57 | MAPK13 | 0.86334794 |
| 58 | FGFR2 | 0.85850037 |
| 59 | MAP3K2 | 0.84276986 |
| 60 | PDPK1 | 0.81276096 |
| 61 | CAMK2G | 0.80389378 |
| 62 | EPHA2 | 0.80284349 |
| 63 | TNK2 | 0.79014589 |
| 64 | KSR1 | 0.78748189 |
| 65 | CAMK2A | 0.76610139 |
| 66 | STK11 | 0.74654697 |
| 67 | MAPK12 | 0.73954518 |
| 68 | PDK4 | 0.73061162 |
| 69 | PDK3 | 0.73061162 |
| 70 | PDGFRB | 0.73019815 |
| 71 | CAMK1D | 0.72699844 |
| 72 | ERBB4 | 0.70271938 |
| 73 | PRPF4B | 0.69781071 |
| 74 | PDK1 | 0.69091751 |
| 75 | FES | 0.67718594 |
| 76 | RET | 0.67572346 |
| 77 | MET | 0.67204221 |
| 78 | CAMK1 | 0.66406727 |
| 79 | PRKAA2 | 0.65495192 |
| 80 | FRK | 0.65235504 |
| 81 | PRKAA1 | 0.64799771 |
| 82 | ACVR1B | 0.63846208 |
| 83 | PNCK | 0.62225222 |
| 84 | CAMK2B | 0.61598826 |
| 85 | NEK6 | 0.61309331 |
| 86 | PRKCZ | 0.60810149 |
| 87 | CDC42BPA | 0.60444458 |
| 88 | BMX | 0.57287337 |
| 89 | RPS6KA3 | 0.57051574 |
| 90 | CAMK4 | 0.56745500 |
| 91 | GRK5 | 0.55691974 |
| 92 | EPHB1 | 0.54787734 |
| 93 | PRKCE | 0.54009774 |
| 94 | LATS1 | 0.53922734 |
| 95 | FGFR3 | 0.52796947 |
| 96 | NEK1 | 0.52297515 |
| 97 | ICK | 0.52281637 |
| 98 | SIK2 | 0.51886533 |
| 99 | ROCK1 | 0.51784260 |
| 100 | PKN1 | 0.49256810 |
| 101 | PTK6 | 0.48142464 |
| 102 | * PRKACG | 0.47444807 |
| 103 | PRKD2 | 0.46966514 |
| 104 | PRKG1 | 0.46803707 |
| 105 | NEK9 | 0.46434369 |
| 106 | CSNK1A1L | 0.46144135 |
| 107 | CAMK2D | 0.45227976 |
| 108 | PDGFRA | 0.45181700 |
| 109 | MUSK | 0.44994558 |
| 110 | MARK2 | 0.44880918 |
| 111 | DYRK1A | 0.44819168 |
| 112 | * PRKCA | 0.44601387 |
| 113 | TAOK1 | 0.43997197 |
| 114 | MAPK10 | 0.43574904 |
| 115 | LATS2 | 0.43398298 |
| 116 | CDK15 | 0.43092681 |
| 117 | PKN2 | 0.42567263 |
| 118 | ERBB2 | 0.42300798 |
| 119 | BCR | 0.42297583 |
| 120 | FYN | 0.41860592 |
| 121 | TRPM7 | 0.40784562 |
| 122 | NLK | 0.40711894 |
| 123 | DDR2 | 0.40137573 |
| 124 | ROCK2 | 0.40031409 |
| 125 | CDK18 | 0.39908713 |
| 126 | PRKD1 | 0.38198005 |
| 127 | JAK1 | 0.38030774 |
| 128 | MAP2K1 | 0.37724912 |
| 129 | * PRKACA | 0.37672882 |
| 130 | MAPK7 | 0.36670807 |
| 131 | PTK2 | 0.36558460 |
| 132 | FER | 0.35807284 |
| 133 | STK24 | 0.35130870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.09357761 |
| 2 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.08818591 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19873289 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.11036699 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03458460 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01380824 |
| 7 | * Bile secretion_Homo sapiens_hsa04976 | 1.92766042 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83702648 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82251397 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.79150190 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.77535721 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76899313 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75335720 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73541513 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.73423583 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72715691 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.67461413 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65458854 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59732809 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53892211 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53450437 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.48433065 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43934750 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43579919 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.42596638 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.40808912 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35982169 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30314691 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.28288703 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26391337 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25936093 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25764055 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.20652050 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.17475016 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13517534 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12382787 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07231660 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.06359022 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05961614 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05714075 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03239801 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.01832939 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00758392 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96434845 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95634747 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93204573 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91899715 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89704847 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88916924 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.87832786 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.87232162 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86794086 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85715450 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.84990431 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82436167 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82187334 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81569318 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80813739 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78217735 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77952931 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76352795 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74896114 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73050795 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73034127 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72726259 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.72073632 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70953184 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70919424 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70905230 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69307141 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68181980 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64321715 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.63354230 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62999303 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62852663 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62112264 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61499475 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60986078 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60520592 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.59348133 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59174849 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58806421 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58704294 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.58461191 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57128711 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.56650188 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55662597 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55501180 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55486361 |
| 90 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.55381422 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54580493 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53249366 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52996012 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.52501833 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52261894 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.51511838 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51189632 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50928473 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.50906048 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50794489 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50725696 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48768450 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48150814 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47667123 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47102389 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46895970 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45645503 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45159377 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44721007 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43564373 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43251442 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42050591 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41229421 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41135995 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40699830 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40522292 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39130886 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39115199 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38467993 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36377071 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35996324 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35802618 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.33888931 |

